Brief: Emmaus Life Sciences Reports Q2 2022 Results
15/08/2022 22:33
Aug 15 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS LIFE SCIENCES REPORTS Q2 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* EMMAUS LIFE SCIENCES INC - QTRLY LOSS PER SHARE $0.18
* EMMAUS LIFE SCIENCES INC - QTRLY CASH AND CASH EQUIVALENTS
$1.0
MILLION
Source text for Eikon: [https://bit.ly/3AnkivK]
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns